Table 3.
Treatment | Fasting blood glucose concentration (mg/dL) | |||||
---|---|---|---|---|---|---|
Day 0 | Day 3 | Day 7 | Day 14 | Day 21 | Day 30 | |
Normal control | 94.6 ± 2.5 | 94 ± 1.5 | 95 ± 2.1 | 95.9 ± 1.9 | 96 ± 4.7 | 96 ± 1.7 |
Diabetic control | 97.2 ± 4.3 | 309 ± 5.3 | 365 ± 7.4 | 412 ± 6.5 | 418 ± 4.3 | 422 ± 5.4 |
Diabetic + treated | 97 ± 2.8 | 305 ± 4.4 | 238 ± 3.7 | 175 ± 4.9 | 135 ± 8.8 | 113 ± 3.5* |
Diabetic + glibenclamide | 96.5 ± 3.1 | 303 ± 2.9 | 215 ± 4.9 | 161 ± 3.3 | 125 ± 6.7 | 106 ± 2.5* |
Values are expressed as mean ± SD (n = 6 rats). *Significance level among different groups at P < 0.05.